Cardiac Amyloidosis Machine Learning-Based Notification Software

FDA product code SHP · Class II (moderate risk) · 21 CFR 870.2380 · Cardiovascular

Cardiac Amyloidosis machine learning-based notification software employs machine learning techniques to suggest the likelihood of cardiac amyloidosis for further referral or diagnostic follow-up.

1510(k) clearances
0PMA approvals
0recalls

Manufacturers

510(k) clearances

510(k)DeviceApplicantDecision
K253801ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)SHP · Traditional Anumana, Inc.04/07/2026SE